BIOFIRE® Respiratory 2.1-EZ (RP2.1- EZ) Panel (EUA)* by bioMérieux USA
Related Products
.jpg.ashx?width=100&height=100&bgcolor=white)
Status:
Reviewer
Member since: 2023
Organization: St Joseph's Health
-
- Ease of use
- After sales service
- Value for money
This instrument is a valuable part of laboratory medicine.
Application Area: Detection of Respiratory Viruses
"The film array is easy to use, giving accurate, reproducible results in a timely fashion. The ED and pediatric population has benefitted the most in receiving rapid treatment and diagnosis. The after sales care is very good, troubleshooting, replacing modules and responding to failed cartridges is very positive. The value for the money is also top notch, the doctor gets a quick turnaround time on results, the patient benefits with accurate treatment decisions and the hospital gains correct placement of the patient. It is a win-win-win for all involved."
Review date: 18 Apr 2023 | BIOFIRE® Respiratory 2.1-EZ (RP2.1- EZ) Panel (EUA)*
Status:
Reviewer Member since: 2023
Organization: WVU Medicine
-
- Ease of use
- After sales service
- Value for money
Standard of care for our clinic when dealing with respiratory illness
Application Area:respiratory panel to assess cause of symptoms
"Good machine. Not too difficult to use. The biggest drawback for me is clinical significance of the results. For example, if a patient is very sick but only tests positive for rhinovirus, are they just hit really badly with it or is there something else going on? This is still an improvement from saying flu and COVID testing was negative and I don't know why you're sick. The other drawback I run into is cost to patient, though typically I do warn them if we're going to do this test that it can be pricey but does give a name to things."
Review date: 17 Apr 2023 | BIOFIRE® Respiratory 2.1-EZ (RP2.1- EZ) Panel (EUA)*
Status:
Reviewer Member since: 2023
Organization: Riverside Medical Center
-
- Ease of use
- After sales service
- Value for money
Love this instrument
Application Area:Respiratory Viral pathogen panel used by Infectious Disease and Pulmonology
"This product is great for our smaller lab size ease of use and quick turnaround time for multiple samples. This product is very easy to use and gives the physicians exactly what they need."
Review date: 17 Apr 2023 | BIOFIRE® Respiratory 2.1-EZ (RP2.1- EZ) Panel (EUA)*
The BIOFIRE RP2.1-EZ Panel (EUA)* detects and identifies a comprehensive menu of respiratory pathogens, including 15 viruses and 4 bacteria, providing an alternative to targeted SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) testing. This helps to ensure that your patients can receive the right treatment, the first time, potentially leading to higher patient satisfaction and lower costs. And as the name implies, it’s easy and can be performed right in your office with a CLIA Certificate of Waiver.
- Detects SARS-CoV-2 and identifies respiratory pathogens.
- Results are available in about 45 minutes.
- Designed to run on the BIOFIRE® FILMARRAY® 2.0 EZ System configuration.
*This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; This product has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and, The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Product Overview
BIOFIRE® Respiratory 2.1-EZ (RP2.1- EZ) Panel (EUA)*
Manufacturer bioMérieux USA | Available in North America, South Central America
4.5 / 5.0 | 3 reviews